| Trade mark | ||
|---|---|---|
| (210) | Application number | 2021 2563 |
| (220) | Date of filing the application | 2021-12-17 |
| (111) | Registration number | 86985 |
| (151) | Registration date | 2022-06-13 |
| (181) | Expire | 2031-12-17 |
| (442) | Date of application publication, bulletin No. | 2022-02-25, 2022/04 |
| (450) | Date of registration publication, bulletin No. | 2022-06-27, 2022/12 |
| Legal status |
Registered
|
|
| Reproduction of the mark | ||
| (540) | Hepetra | |
| (531) | Indication of Vienna Classification | |
| Indication concerning colors claimed | ||
| (591) | ||
| Indication of International Classification of Goods and Services, list of goods and (or) services | ||
| (511) |
5 farmaciniai preparatai, tarp jų imunoglobulino preparatai, imunoglobulinai ir hiperimunoglobulinai; farmaciniai preparatai, skirti imunologijai, intensyviajai medicinai, transplantacijos medicinai, virusinių susirgimų prevencijai ir jų gydymui. |
|
| Applicant (731) / Owner (732) | ||
| (732) | Name | Biotest AG |
| Address | Landsteinerstr. 5, 63303 Dreieich | |
| Country | DE | |
| Attorney or representative | ||
| (740) | Name | Vitalija Banaitienė |
| Address | UAB "Tarpinė", p.d. 1202 LT-01007, A. P. Kavoliuko g. 24-152, LT-04328 Vilnius | |
| Country | LT | |
| Disclaimer | ||
| (526) | ||
| Exhibition priority | ||
| (230) | Date, country | |
| Convention priority | ||
| (300) | Convention priority | |
| Date | ||
| Country | ||